What is ChromoLogic?
ChromoLogic LLC operates as an innovation center dedicated to creating advanced biomedical and industrial solutions. In the biomedical sector, the company focuses on areas such as wound care, diagnostics, drug delivery, and telehealth, aiming to improve patient outcomes and save lives. Concurrently, its industrial solutions address critical needs in supply chain traceability and security. ChromoLogic serves a broad spectrum of clients, including healthcare providers and industries that require robust asset management and security protocols. The company's commitment extends to sustainability and community outreach, driving the development of impactful technologies designed to tackle underserved societal challenges.
How much funding has ChromoLogic raised?
ChromoLogic has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$756K
Debt (2020): $350K with participation from PPP
Debt (2021): $756K led by PPP
Key Investors in ChromoLogic
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for ChromoLogic?
The recent major strategic investment signifies a pivotal moment for ChromoLogic, likely enabling the company to accelerate its research and development efforts, scale its operations, and expand its market reach. This enterprise-level funding suggests a focus on significant growth and the commercialization of its innovative biomedical and industrial technologies. Future strategic initiatives may involve further partnerships, market penetration, and the continuous enhancement of its product portfolio to address evolving healthcare and security demands.
See full ChromoLogic company page
